Kacee Albano

Senior Molecular Oncology Specialist @ Agendia | Driving Oncology Sales

Role: Senior Molecular Oncology Specialist at Agendia
Location: Las Vegas, NV, US
LinkedIn followers: 500 followers

About Kacee Albano

I\'m excited to join Agendia\'s mission of \"Illuminating Tumor Biology to Guide Early Breast Cancer Treatment.\" With almost a decade of experience in diagnostic oncology sales, my current role as Senior Molecular Oncology Specialist focuses on executing impactful sales strategies to drive sales and national field leadership.A consistent top performer in my previous role at Guardant Health, I’ve played a key role in new hire training, regional product rollouts, and cross-team alignment initiatives. My commitment to collaboration and growth has been recognized through multiple honors, including the President’s Club, One Guardant, and Founder’s Award.

Experience

Senior Molecular Oncology Specialist
Agendia
Nov 2025 — Present · Las Vegas, NV, US

Education

Louisiana State University
Bachelor, Mass Communications
1998 — 2002

Skills

Ent
Sales
General Surgery
Surgical Instruments
Sales Operations
Gynecology
Urology
Cold Calling
Surgeons
Medical Devices
Ob/Gyn
Medical Sales
Interventional Radiology
Sales Process
Hospitals
Strategic Planning
Cardiothoracic Surgery
Capital Equipment
Selling
Operating Room
Disposables
Colorectal Surgery
Surgery
Negotiation
Bariatric Surgery
Pharmaceutical Sales

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@agendia.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Agendia

Biotechnology · 224 employees · Founded 2003 · Irvine, California, United States

Agendia, a precision oncology company, helps physicians and patients make personalized treatment decisions in early-stage breast cancer. MammaPrint® (MP), 70-gene breast cancer recurrence assay, is the only FDA-cleared (microarray) risk of recurrence test and is CE marked (IVDR-certified). BluePrint®(BP), 80-gene molecular subtyping assay, evaluates the underlying biology of a tumor to determine growth drivers. MP+BP are commercially available genomic tests, supported by clinical, guideline, peer-reviewed, and real-world evidence. They can be ordered on core biopsies or surgical specimens.* *FDA Intended Use: the test is performed for breast cancer patients with Stage I or Stage II disease with tumor size ≤5.0cm and lymph node negative. The MP FFPE result is indicated for use by physicians as a prognostic marker only, along with other clinicopathological factors. Coverage criteria for majority of US health plans include early-stage breast cancer, tumor size less than or equal to 5.0cm (≤5.0cm), up to 3 positive lymph nodes, independent of receptor status, as validated in the 6,693 patient MINDACT trial. IVDR-CE mark Intended Use: you are a female breast cancer patient with Stage I or Stage II disease who is lymph node negative or lymph node positive with up to 3 positive nodes and for patients with stage III disease. The MP FFPE result is indicated for use by physicians and should be interpreted with other clinico-pathological factors. BP was developed and its performance characteristics determined by Agendia. It has not been cleared or approved by the US FDA, which determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational or for research. This test was performed at Agendia, Inc (05D10•••50), which is certified under CLIA as qualified to perform high-complexity clinical laboratory testing. It is CE-marked for use in Europe. Social media policy: agendia.com/legal-compliance

agendia.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Kacee Albano

Experience

Senior Molecular Oncology Specialist

Education

Louisiana State University

Skills

Find verified contacts for anyone on LinkedIn